- Report
- August 2023
- 114 Pages
Global
From €4708EUR$4,900USD£4,042GBP
- Report
- February 2024
- 117 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- October 2023
- 146 Pages
Global
From €3389EUR$3,528USD£2,910GBP
€3987EUR$4,150USD£3,423GBP
- Report
- October 2023
Global
From €3459EUR$3,600USD£2,969GBP
- Report
- November 2023
- 110 Pages
Global
From €2834EUR$2,950USD£2,433GBP
- Report
- November 2023
- 120 Pages
Europe
From €4228EUR$4,400USD£3,629GBP
- Report
- February 2024
- 95 Pages
Europe
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4564EUR$4,750USD£3,918GBP
- Report
- April 2024
- 620 Pages
From €6726EUR$7,000USD£5,774GBP
- Report
- September 2021
- 144 Pages
China
From €3843EUR$4,000USD£3,299GBP
- Report
- February 2024
- 72 Pages
South Korea
From €4804EUR$5,000USD£4,124GBP
- Report
- April 2023
- 600 Pages
Global
From €5765EUR$6,000USD£4,949GBP
- Report
- March 2023
- 56 Pages
Global
From €3603EUR$3,750USD£3,093GBP
- Report
- January 2023
- 195 Pages
Latin America
From €4804EUR$5,000USD£4,124GBP
- Report
- January 2023
- 178 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- November 2022
- 44 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- October 2022
- 348 Pages
Indonesia, Malaysia, Singapore Indonesia, Malaysia, Singapore
From €4804EUR$5,000USD£4,124GBP
- Report
- October 2022
- 220 Pages
United States
From €4804EUR$5,000USD£4,124GBP
- Report
- June 2022
- 55 Pages
India
From €4804EUR$5,000USD£4,124GBP
- Report
- March 2022
- 312 Pages
Global
From €6726EUR$7,000USD£5,774GBP
The HbA1C Testing market within the Biotechnology industry is a rapidly growing sector. It is used to measure the average amount of glucose in the blood over a period of two to three months. This test is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to detect pre-diabetes and to monitor the risk of developing diabetes.
The HbA1C Testing market is driven by the increasing prevalence of diabetes, the growing awareness of the importance of early diagnosis and treatment, and the availability of advanced testing technologies. The market is also supported by the increasing demand for point-of-care testing and the development of new products.
Some of the major companies in the HbA1C Testing market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Alere, and Bio-Rad Laboratories. Show Less Read more